2m 2m 2m 2m 2m 2m 2m
Lite Strategy (LITS)
NASDAQ
$1.11-$0.003 (-0.27%)
Price as of Sep 11, 2026 7:50 PM EDT- $37.8MMarket Cap
- -62.12%1-Year Change
- BiotechnologyIndustry
Lite Strategy (LITS)
$1.11-$0.003 (-0.27%)
LITS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.11 | ||
Change | +$0.05 (+4.72%) | ||
Open | $1.06 | ||
High | $1.12 | ||
Low | $1.06 | ||
Previous Close | $1.06 | ||
Volume | 278,100 | ||
30-Day Average Volume | 287,529 | ||
1-Week Change | -2.63% | ||
1-Month Change | 23.17% | ||
1-Year Change | -62.12% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 34.0M | ||
Total Assets | $57.8M | ||
Market Cap | $37.8M | ||
Enterprise Value | $30.2M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$23.7M | ||
Free Cash Flow | -$1.5M | ||
EBIT | -$23.7M | ||
EBITDA | -$23.7M | ||
Net Working Capital | $10.0M | ||
EPS | -$0.66 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -2 | ||
PEG | -0 | ||
Price/Free Cash Flow | -25 | ||
Price/Operating Cash Flow | -25 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||